Gradientech is leading the field of ultra-rapid antibiotic susceptibility testing. We develop next-generation diagnostics that provide patients with the right dose of the right medicine at the right time. Our goal is to improve patient outcomes while reducing healthcare costs, for the benefit of society.
VISIT SITEGradientech AB
